Viewing Study NCT00328861


Ignite Creation Date: 2025-12-24 @ 11:50 AM
Ignite Modification Date: 2026-01-12 @ 9:58 PM
Study NCT ID: NCT00328861
Status: COMPLETED
Last Update Posted: 2012-11-05
First Post: 2006-05-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: 060169
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Steven A. Rosenberg, M.D./National Cancer Institute
Old Organization: National Institutes of Health

Collaborators